PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
119.000 |
Evidence |
|
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
119.000 |
Evidence |
|
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
119.000 |
Evidence |
|
IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
119.000 |
Evidence |
|
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
119.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
119.000 |
Evidence |
|
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
LYN |
LYN: Tyrosine-protein kinase Lyn |
119.000 |
Evidence |
|
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
119.000 |
Evidence |
|
HCK |
IPI00029769 |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
119.000 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
STAT3 |
|
119.000 |
Evidence |
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
119.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
CSK |
CSK: Tyrosine-protein kinase CSK |
119.000 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
119.000 |
Evidence |
|
BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
BID |
BID: BH3-interacting domain death agonist |
119.000 |
Evidence |
|
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
119.000 |
Evidence |
|
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
119.000 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
119.000 |
Evidence |
O
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
119.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
119.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
119.000 |
Evidence |
|
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
STAT3 |
|
119.000 |
Evidence |
|
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
119.000 |
Evidence |
|
IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
LIF |
LIF, HILDA: Leukemia inhibitory factor precursor |
119.000 |
Evidence |
|
CSK |
CSK: Tyrosine-protein kinase CSK |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
119.000 |
Evidence |
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
119.000 |
Evidence |
|